{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT03012594","recordId":"NCT03012594","peptideSlug":"lanreotide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03012594-lanreotide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct03012594.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct03012594.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2017-01-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2017-01-04","publishedAt":"2026-08-23","recordId":"NCT03012594","recordSha256":"478452439ff03903c64bf8f753738424f8c5eff0a2388de091333d9c1a1f0307","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03012594?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Outcome Measures","Study Description","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2017-01-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2017-01-13","publishedAt":"2026-08-23","recordId":"NCT03012594","recordSha256":"d3eba984f7fe86f1fbb771a1de96161360a4c1bbcd73e0cf6a2449d772fa0b42","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03012594?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2018-02-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2018-02-05","publishedAt":"2026-08-23","recordId":"NCT03012594","recordSha256":"82b5756e1824a05d85453ff90a336c4e34790d78e3068b352f1bd82475477897","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03012594?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2019-02-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2019-02-18","publishedAt":"2026-08-23","recordId":"NCT03012594","recordSha256":"330cfeb10d11654521eb9c16f407e0ad528d72c56c4a08c81073900a93d10e93","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03012594?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","Contacts/Locations","Document Section","Eligibility","Limitations and Caveats","More Information","Outcome Measures","Outcome Measures (Results)","Oversight","Participant Flow","Sponsor/Collaborators","Study Design","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2020-12-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"lanreotide","submittedDate":"2020-12-23","publishedAt":"2026-08-23","recordId":"NCT03012594","recordSha256":"41f4e13a4de6d11bb86f8895566356abf7bcc345d00c4ae6c5c0a0798a2c98f2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03012594?a=6&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"5c00e3a7fef366688aeee21c4a1e075e0f821cd8df0da46e27be136516cbc737"}}